세계의 뇌자도 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has recently published an extensive report on the global Magnetoencephalography Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Magnetoencephalography Market Size (2024E): US$304.6 Mn
• Projected Market Value (2031F): US$449.0 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 5.7%

Magnetoencephalography Market - Report Scope:

The Magnetoencephalography (MEG) Market encompasses a variety of advanced neuroimaging techniques used to map brain activity by recording magnetic fields produced by neuronal electrical currents. These techniques are essential for the diagnosis and research of neurological conditions such as epilepsy, brain tumors, and neurodegenerative diseases. The market serves diverse segments, including hospitals, research institutions, and diagnostic centers. Growth is driven by increasing demand for non-invasive brain imaging solutions, advancements in neuroimaging technologies, and the expanding application of MEG in cognitive neuroscience and psychiatric research.

Market Growth Drivers:

Several key factors are driving the global Magnetoencephalography Market. The rising prevalence of neurological disorders worldwide, coupled with the growing need for accurate and non-invasive diagnostic tools, is boosting the market's growth. Technological advancements in MEG systems, such as the development of lightweight and more sensitive sensors, have improved the precision and applicability of MEG in various clinical and research settings. Additionally, the increasing focus on personalized medicine and the demand for functional neuroimaging techniques that can provide real-time brain activity data drive the market. Enhanced research and development activities, along with the introduction of portable and wearable MEG systems, contribute to market growth by offering more tailored solutions for diverse healthcare needs.

Market Restraints:

Despite promising growth prospects, the Magnetoencephalography Market faces challenges related to the high costs associated with MEG systems and the complexity of their operation. Market growth can be hindered by the availability of alternative neuroimaging techniques, such as functional MRI (fMRI) and electroencephalography (EEG), which may be preferred by some institutions due to their lower costs and broader availability. Additionally, concerns about the accessibility of MEG technology in low-resource settings and the need for specialized training for operators pose challenges for market expansion. Addressing these issues requires ongoing investment in cost-reduction strategies, training programs, and the development of more user-friendly systems.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of MEG in psychiatric research and cognitive neuroscience. The development of advanced MEG technologies, such as optically pumped magnetometers (OPMs), caters to the growing need for more precise and versatile brain imaging solutions. The expansion of MEG applications in the early diagnosis of neurodegenerative diseases and the monitoring of brain activity during neurosurgical procedures provides new avenues for market growth. Strategic partnerships, investments in AI-driven data analysis tools, and the introduction of portable MEG systems are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Magnetoencephalography Market globally?
• Which types and formats of MEG systems are leading the adoption in various clinical and research settings?
• How are technological advancements influencing the competitive landscape of the Magnetoencephalography Market?
• Who are the key players in the Magnetoencephalography Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Magnetoencephalography Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Magnetoencephalography Market, including Elekta AB, Compumedics Limited, and Ricoh Company, Ltd., focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced MEG solutions and explore new clinical applications. Collaborations with academic institutions, healthcare providers, and technology partners facilitate market access and promote the adoption of new MEG technologies. Emphasis on precision medicine, high-quality imaging systems, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Magnetoencephalography Market landscape.

Key Companies Profiled:

• Compumedics Limited
• MEGIN
• Ricoh
• CTF MEG NEURO INNOVATIONS, INC.
• FieldLine Inc.
• Cerca Magnetics Limited.

Magnetoencephalography Market Industry Segmentation

By Application

• Clinical
• Research

By End User

• Hospitals
• Imaging Centers
• Academic and Research Institutes

By Region

• North America
• Europe
• Asia Pacific
• The Middle East and Africa
• Latin America

Table of Contents

1. Executive Summary

• 1.1. Global Magnetoencephalography Market Snapshot, 2024-2031
• 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
  • 2.3.3. Global Healthcare Spending Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Value Chain Analysis
• 3.3. Key Deals and Mergers
• 3.4. PESTLE Analysis
• 3.5. Porter's Five Force Analysis

4. Global Magnetoencephalography Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
  • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
• 4.3. Global Magnetoencephalography Market Outlook: Application
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
  • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 4.3.3.1. Clinical
      • 4.3.3.1.1. Dementia
      • 4.3.3.1.2. Autism
      • 4.3.3.1.3. Schizophrenia
      • 4.3.3.1.4. Multiple Sclerosis
      • 4.3.3.1.5. Stroke
      • 4.3.3.1.6. Epilepsy
      • 4.3.3.1.7. Others
    • 4.3.3.2. Research
• 4.4. Market Attractiveness Analysis: Application
• 4.5. Global Magnetoencephalography Market Outlook: End User
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 4.5.3.1. Hospitals
    • 4.5.3.2. Imaging Centers
    • 4.5.3.3. Academic and Research Institutes
• 4.6. Market Attractiveness Analysis: End User

5. Global Magnetoencephalography Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
• 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Magnetoencephalography Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 6.2.1. By Country
  • 6.2.2. By Application
  • 6.2.3. By End User
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 6.4.1. Clinical
    • 6.4.1.1. Dementia
    • 6.4.1.2. Autism
    • 6.4.1.3. Schizophrenia
    • 6.4.1.4. Multiple Sclerosis
    • 6.4.1.5. Stroke
    • 6.4.1.6. Epilepsy
    • 6.4.1.7. Others
  • 6.4.2. Research
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
  • 6.5.1. Hospitals
  • 6.5.2. Imaging Centers
  • 6.5.3. Academic and Research Institutes
• 6.6. Market Attractiveness Analysis

7. Europe Magnetoencephalography Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 7.2.1. By Country
  • 7.2.2. By Application
  • 7.2.3. By End User
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 7.4.1. Clinical
    • 7.4.1.1. Dementia
    • 7.4.1.2. Autism
    • 7.4.1.3. Schizophrenia
    • 7.4.1.4. Multiple Sclerosis
    • 7.4.1.5. Stroke
    • 7.4.1.6. Epilepsy
    • 7.4.1.7. Others
  • 7.4.2. Research
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
  • 7.5.1. Hospitals
  • 7.5.2. Imaging Centers
  • 7.5.3. Academic and Research Institutes
• 7.6. Market Attractiveness Analysis

8. East Asia Magnetoencephalography Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 8.2.1. By Country
  • 8.2.2. By Application
  • 8.2.3. By End User
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 8.4.1. Clinical
    • 8.4.1.1. Dementia
    • 8.4.1.2. Autism
    • 8.4.1.3. Schizophrenia
    • 8.4.1.4. Multiple Sclerosis
    • 8.4.1.5. Stroke
    • 8.4.1.6. Epilepsy
    • 8.4.1.7. Others
  • 8.4.2. Research
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
  • 8.5.1. Hospitals
  • 8.5.2. Imaging Centers
  • 8.5.3. Academic and Research Institutes
• 8.6. Market Attractiveness Analysis

9. South Asia & Oceania Magnetoencephalography Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 9.2.1. By Country
  • 9.2.2. By Application
  • 9.2.3. By End User
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 9.4.1. Clinical
    • 9.4.1.1. Dementia
    • 9.4.1.2. Autism
    • 9.4.1.3. Schizophrenia
    • 9.4.1.4. Multiple Sclerosis
    • 9.4.1.5. Stroke
    • 9.4.1.6. Epilepsy
    • 9.4.1.7. Others
  • 9.4.2. Research
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
  • 9.5.1. Hospitals
  • 9.5.2. Imaging Centers
  • 9.5.3. Academic and Research Institutes
• 9.6. Market Attractiveness Analysis

10. Latin America Magnetoencephalography Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 10.2.1. By Country
  • 10.2.2. By Application
  • 10.2.3. By End User
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 10.4.1. Clinical
    • 10.4.1.1. Dementia
    • 10.4.1.2. Autism
    • 10.4.1.3. Schizophrenia
    • 10.4.1.4. Multiple Sclerosis
    • 10.4.1.5. Stroke
    • 10.4.1.6. Epilepsy
    • 10.4.1.7. Others
  • 10.4.2. Research
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
  • 10.5.1. Hospitals
  • 10.5.2. Imaging Centers
  • 10.5.3. Academic and Research Institutes
• 10.6. Market Attractiveness Analysis

11. Middle East & Africa Magnetoencephalography Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 11.2.1. By Country
  • 11.2.2. By Application
  • 11.2.3. By End User
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 11.4.1. Clinical
    • 11.4.1.1. Dementia
    • 11.4.1.2. Autism
    • 11.4.1.3. Schizophrenia
    • 11.4.1.4. Multiple Sclerosis
    • 11.4.1.5. Stroke
    • 11.4.1.6. Epilepsy
    • 11.4.1.7. Others
  • 11.4.2. Research
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
  • 11.5.1. Hospitals
  • 11.5.2. Imaging Centers
  • 11.5.3. Academic and Research Institutes
• 11.6. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Compumedics Limited
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. MEGIN
  • 12.3.3. Ricoh
  • 12.3.4. CTF MEG NEURO INNOVATIONS, INC.
  • 12.3.5. FieldLine Inc.
  • 12.3.6. Cerca Magnetics Limited.

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations